The effect of sambiloto tablet (AS201-01) on placental Chondroitin Sulfate A (CSA) expression of pregnant mice infected by Plasmodium berghei
Downloads
Objectives: To determine the effect of Sambiloto tablet (AS201-01) in reducing the placental Chondroitin Sulfate A (CSA) Expression of pregnant mice infected Plasmodiumberghei.
Materials and Methods: Experimental study using 24 pregnant mice were divided into 4 groups with randomization. Uninfected group, the placebo group, the Sambiloto tablet (AS201-01) group and the DHP tablet (as a standart drug) group. The last three groups, were infected with P. bergheion day 9th of pregnancy, and the treatment was started at day 11th of pregnancy, and samples were terminated at day 15th of pregnancy by surgery. Placental sampling were stained with Tunnel assay to measure placental CSA antibodies.
Results: The placental Chondroitin Sulfate A (CSA) expression. Uninfected group compared to Sambiloto tablet (AS201-01) groups was not significantly different (p>0.05), uninfected group compared with the other treatment groups differ meaningfully (p<0.05). Placebo group compared with all groups significantly different (p<0.05). Sambiloto tablet (AS201-01) group compared to uninfected group (p>0.05) was not significantly different, with another group was significantly different (p<0.05). DHP tablet group compared to all the groups was significantly different (p<0.05).
Conclusion: Placental Chondroitin Sulfate A (CSA)expression of mice infected by Plasmodium berghei treated with Sambiloto tablet (AS201-01) lower than DHP tablet.
Gitau GM, Eldred JM. Malaria in pregnancy: clinical, therapeutic and prophylactic consider-ations. The Obstetrician & Gynaecologist. 2005;7 (1):5-11.
Desai M, ter Kuile FO, Nosten F et al. Epidemio-logy and burden of malaria in pregnancy. The Lancet Infectious Diseases. 2007;7(2):93-104.
Rogerson SJ, Hviid L, Duffy PE, et al. Malaria in pregnancy: pathogenesis and immunity. The Lancet Infectious Diseases. 2007;28;7(2):105-17.
Houmsou RS, Amuta EU, Sar TT, Adie AA. Malarial infection in pregnant women attending antenatal clinics in gboko, Benue State, Nigeria. International journal of Academic Research. 2010;2 (1).
Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. Elsevier Health Sciences. [cited 2014 Aug 22].
Kidima WB. Syncytiotrophoblast functions and fetal growth restriction during placental malaria: updates and implication for future interventions. BioMed Research International. 2015;26.
Brabin BJ, Romagosa C, Abdelgalil S et al. The sick placenta ” the role of malaria. Placenta. 2004;25(5):359-78.
Harijanto PN, Nugroho A, Gunawan CA. Malaria, dari Molekuler ke Klinis. Jakarta: EGC. 2009.
Hafid AF, Retnowati D, Widyawaruyanti A. The combination therapy model of Andrographis paniculata extract and chloroquine on Plasmodium berghei infected mice. Asian J Pharm Clin Res. 2015;8(2):205-8.
Nindatu M, Widyawaruyanti A, Syafruddin D, Prospek senyawa flavanoid terisoprenilasi dari kulit batang cempedak (Artocarpus champeden Spreng) terhadap pathogenesis malaria. Jurnal Kedokteran dan Kesehatan. 2008;1-6.
Biagini GA, O'Neill PM, Nzila A et al. Antimalarial chemotherapy: young guns or back to the future? Trends in Parasitology. 2003;19 (11):479-87.
Widyawaruyanti A, Hafid A, Radjaram A, et al. Pengembangan Fitofarmaka Obat Malaria dan Fraksi Diterpen Lakton Herba Sambiloto (Andro-graphis paniculata Nees), Research Report, DP2M 2009/2010 Year II. Surabaya: LPPM Universitas Airlangga; 2010.
Prasetyo B and Widyawaruyanti A. Pengaruh tablet sambiloto terhadap morfologi janin mencit Balb/c bunting yang mendapat infeksi Plasmodium ber-ghei, Research Report. Surabaya: LPPM Universi-tas Airlangga; 2016.
Rachmat J, Prasetyo B, Widyawaruyanti A, Widjiati. Perbandingan pemberian tablet sambiloto dengan dihydroartemisinin-piperaquine phosphate terhadap akumulasi parasit plasenta dan histopato-logi plasenta. Research Report. Surabaya: LPPM Universitas Airlangga; 2017.
Ratih DN, Prasetyo B, Widyawaruyanti A, Widjiati. Perbandingan Indeks Apoptosis Plasenta Mencit Bunting Diinfeksi Plasmodium berghei Yang Diberikan Tablet Sambiloto (As201-01) Dengan Dihydroartemisinin–Piperaquine Phospha-te. Research Report. Surabaya: LPPM Universitas Airlangga; 2017.
Indriani ED, Prasetyo B, Widyawaruyanti B. Perbandingan Ekspresi COX-2 Plasenta Mencit Bunting Diinfeksi Plasmodium berghei Yang Diberikan Tablet Sambiloto (As201-01) Dengan Dihydroartemisinin – Piperaquine Phosphate. Research Report. Surabaya: LPPM Universitas Airlangga; 2017.
Yustinasari, Prasetyo B, Widyawaruyanti A, Perbandingan Ekspresi TLR-4 Plasenta Mencit Bunting Diinfeksi Plasmodium berghei Yang Diberikan Tablet Sambiloto (As201-01) Dengan Dihydroartemisinin – Piperaquine Phosphate. Research Report. Surabaya: LPPM Universitas Airlangga; 2017.
Widyawati T. Aspek farmakologi sambiloto (An-drographis paniculata Nees). Majalah Kedokteran Nusantara. 2007;40(3):216-22.
Hviid L, Marinho CR, Staalsoe T, Penha-Gonçalves C. Of mice and women: rodent models of placental malaria. Trends in Parasitology. 2010;26(8):412-9.
Amori G and Clout M. Rodents on islands: a conservation challenge. Aciar Monograph Series. 2003;96:63-8.
Fried M, Muga RO, Misore AO, Duffy PE. Malaria elicits type 1 cytokines in the human placenta: IFN-γ and TNF-α associated with pregnancy outcomes. The Journal of Immunology. 1998;160(5):2523-30.
Salanti A, Staalsoe T, Lavstsen T et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A adhering Plasmo-dium falciparum involved in pregnancy-associated malaria. Molecular Microbiology. 2003;49 (1):179-91.
Fried M, Avril M, Chaturvedi R et al. Multilabora-tory approach to preclinical evaluation of vaccine immunogens for placental malaria. Infection and Immunity. 2013;81(2):487-95.
Warouw NN. Malaria pada kehamilan. In: Harjanto P, Agung N, Gunawan AC (eds). Malaria dari Molekuler ke Klinis. 2nd edn, Jakarta: EGC; 2010. p. 195-223.
Kraemer SM and Smith JD. A family affair: var genes, PfEMP1 binding, and malaria disease. Current Opinion in Microbiology. 2006;9(4):374-80.
Fried M, Nosten F, Brockman A et al. Maternal antibodies block malaria. Nature. 1998;395 (6705):851-2.
Rogerson SJ, Brown HC, Pollina E et al. Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women. Infection and Immunity. 2003;71(1):267-70.
Bulmer JN, Rasheed FN, Francis N et al. Placental malaria. I. Pathological classification. Histopatho-logy. 1993;22(3):211-8.
Menendez C, Ordi J, Ismail MR et al. The impact of placental malaria on gestational age and birth weight. The Journal of Infectious Diseases. 2000; 181(5):1740-5.
Widyawaruyanti A, Safarianti TL, Ilmi H et al. Antimalarial effects of Andrographis paniculata nees on Plamodium falciparum food vacuole. Surabaya: ISPSA; 2015..
Iruretagoyena MI, Sepúlveda SE, Lezana JP, et al. Inhibition of nuclear factor-κB enhances the capacity of immature dendritic cells to induce anti-gen-specific tolerance in experimental autoimmune encephalomyelitis. Journal of Pharmacology and Experimental Therapeutics. 2006;318(1):59-67.
Qin LH, Kong L, Shi GJ et al. Andrographolide inhibits the production of TNF-α and interleukin-12 in lipopolysaccharide-stimulated macrophages: role of mitogen-activated protein kinases. Biological and Pharmaceutical Bulletin 2006;29(2):220-4.
Qin LH, Kong L, Shi GJ et al. Andrographolide inhibits the production of TNF-α and interleukin-12 in lipopolysaccharide-stimulated macrophages: role of mitogen-activated protein kinases. Biological and Pharmaceutical Bulletin. 2006;29(2):220-4.
Lin FL, Wu SJ, Lee SC, Ng LT. Antioxidant, antioedema and analgesic activities of Andro-graphis paniculata extracts and their active consti-tuent andrographolide. Phytotherapy Research. 2009;23(7):958-64.
Van Sinderen M, Cuman C, Winship A et al. The chrondroitin sulfate proteoglycan (CSPG4) regu-lates human trophoblast function. Placenta. 2013;34 (10):907-12.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
